Roche 1H Dx Revenues Flat, Hit by Currency Exchange | GenomeWeb

NEW YORK (GenomeWeb) — Roche reported today that first half revenues for its Diagnostics division were essentially flat year over year as its molecular diagnostics business sales dropped 2 percent due to the negative effects of currency exchange.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.